What is Tara Mind?
Founded in 2022, Tara Mind is a public benefit corporation dedicated to enhancing access to psychedelic-assisted therapy. The company aims to address critical health equity issues that hinder individuals from obtaining effective mental health care, positioning itself as a key player in the evolving landscape of therapeutic interventions.
How much funding has Tara Mind raised?
Tara Mind has raised a total of $11M across 2 funding rounds:
Other Financing Round
$3M
Angel/Seed
$8M
Other Financing Round (2023): $3M with participation from Red Cell Partners
Angel/Seed (2024): $8M led by Crumpton Ventures, Empath Ventures, and Satori Capital
Key Investors in Tara Mind
Satori Capital
Satori Capital is a Texas-based multi-strategy investment firm founded upon the principles of conscious capitalism, likely bringing a value-aligned approach to Tara Mind's mission.
Red Cell Partners
Red Cell Partners is an investment and incubation firm focused on healthcare and national security, suggesting a strategic interest in Tara Mind's innovative approach to mental health solutions.
Crumpton Ventures
Undisclosed investor participating in the funding round.
What's next for Tara Mind?
The substantial enterprise-level backing indicates Tara Mind is poised for significant scaling and expansion. This strategic investment will likely fuel further development of its platform, broader market penetration, and enhanced research into psychedelic-assisted therapies. The company's commitment as a public benefit corporation suggests a continued focus on social impact alongside commercial growth.
See full Tara Mind company page
